No trading signal — this is a routine initial ownership disclosure for an incoming officer. Monitor future Form 4 filings for any open-market purchases or grants that could indicate insider conviction.
Price Chart
Executive Summary
Brigette Roberts filed a Form 3 initial beneficial ownership statement upon becoming Chief Corp. Affairs Officer at Quince Therapeutics. The filing was submitted late due to an administrative delay in obtaining EDGAR credentials. No securities ownership was reported. This is a routine compliance filing with no material financial impact.
Key Facts
- Form 3 filed for Brigette Roberts, new Chief Corp. Affairs Officer at Quince Therapeutics
- Filed late on 2026-06-11, with period of report 2026-05-18, due to administrative delay in obtaining EDGAR filing credentials
- No beneficial ownership of securities reported on the Form 3
Financial Impact
No financial impact — no securities or transactions disclosed
Risk Factors
- Late filing suggests administrative process issues but no substantive risk
- No ownership disclosed — lack of insider skin-in-the-game is not necessarily negative at this stage
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001346566-26-000003 |
| Document: 0001346566-26-000003-index-headers.html | 0001346566-26-000003 |
| Document: 0001346566-26-000003-index.html | 0001346566-26-000003 |
| Document: 0001346566-26-000003.txt | 0001346566-26-000003 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $31.32 $28.59 | ▲ +8.72% | ▲ +7.51% | $30.67 (+2.08%) |
Aug 25, 2026 5w ago | EFFECT | $30.93 $32.11 | ▼ −3.82% | ▼ −4.35% | $30.67 (+0.84%) |
Aug 14, 2026 7w ago | 8-K | $31.34 awaiting T+5 | awaiting T+5 | — | $30.67 (−2.14%) |
Aug 14, 2026 7w ago | Press Release | $31.34 awaiting T+5 | awaiting T+5 | — | $30.67 (−2.14%) |
Aug 5, 2026 8w ago | S-3/A | $28.88 $31.26 | ▲ +8.24% | ▲ +7.89% | $30.67 (+6.20%) |
Jun 11, 2026 16w ago | 3 | $0.9337 $0.9451 | ▲ +1.22% | ▲ +0.55% | $30.67 (+3184.78%) |
May 18, 2026 19w ago | 8-K | $19.90 $24.00 | ▲ +20.60% | ▲ +18.99% | $30.67 (+54.12%) |
Apr 27, 2026 22w ago | DEFA14A | $24.60 $24.60 | · 0.00% | ▼ −1.70% | $30.67 (+24.67%) |
Apr 9, 2026 25w ago | 8-K | $1.24 $1.34 | ▲ +8.06% | ▲ +4.88% | $30.67 (+2373.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access